138 related articles for article (PubMed ID: 33039483)
1. Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.
Costello CM; Hill HE; Brumfiel CM; Yang YW; Swanson DL
J Am Acad Dermatol; 2021 Mar; 84(3):840-841. PubMed ID: 33039483
[No Abstract] [Full Text] [Related]
2. Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors.
Bierbrier R; Esfahani K; Pehr K
J Cutan Med Surg; 2022; 26(6):624-625. PubMed ID: 35980317
[No Abstract] [Full Text] [Related]
3. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
Requena C; Llombart B; Sanmartín O
Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
[TBL] [Abstract][Full Text] [Related]
4. A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor- and mitogen-activated protein kinase kinase inhibitor-induced acneiform eruptions.
Andrews ED; Garg N; Patel AB
J Am Acad Dermatol; 2020 Apr; 82(4):998-1000. PubMed ID: 31604105
[No Abstract] [Full Text] [Related]
5. A systematic review of oral retinoids for treatment of acneiform eruptions induced by epidermal growth factor receptor inhibitors.
Bierbrier R; Lam M; Pehr K
Dermatol Ther; 2022 May; 35(5):e15412. PubMed ID: 35220635
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of a child with MEK inhibitor-induced acneiform eruption with low-dose isotretinoin.
Gupta R; Craddock MF
Pediatr Dermatol; 2022 Jul; 39(4):646-647. PubMed ID: 35896172
[TBL] [Abstract][Full Text] [Related]
7. Differences in Management Between Dermatologists and Oncologists for Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
Oliel S; Bierbrier R; D'Aguanno K; Esfahani K; Pehr K
J Cutan Med Surg; 2024; 28(1):79-81. PubMed ID: 38156654
[No Abstract] [Full Text] [Related]
8. Reader Comment Regarding "Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors".
Fournier C; Sauder MB
J Cutan Med Surg; 2023; 27(3):294. PubMed ID: 36927192
[No Abstract] [Full Text] [Related]
9. Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions.
Chiang HC; Anadkat MJ
J Am Acad Dermatol; 2013 Oct; 69(4):657-8. PubMed ID: 24034378
[No Abstract] [Full Text] [Related]
10. Efficacy of topical epidermal growth factor cream for patients with epidermal growth factor receptor inhibitor-induced acneiform eruption: a randomized controlled trial.
Lee JH; Ju HJ; Kwon HS; Jung HM; Kim GM; Bae JM; An HJ
Br J Dermatol; 2020 Jan; 182(1):219-221. PubMed ID: 31301244
[No Abstract] [Full Text] [Related]
11. Severe EGFR inhibitor-induced acneiform eruption responding to dapsone.
Beshay A; Petersen M; Rhoads JLW
Dermatol Online J; 2021 Jul; 27(7):. PubMed ID: 34391331
[TBL] [Abstract][Full Text] [Related]
12. Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers.
Magnino MZ; Perry DJ; Subramaniam DS; DeKlotz CMC
J Am Acad Dermatol; 2020 Feb; 82(2):486-488. PubMed ID: 31279812
[No Abstract] [Full Text] [Related]
13. Prognostic factors for the development of acneiform eruptions in patients on epidermal growth factor receptor inhibitors.
Bierbrier R; D'Aguanno K; Kasymjanova G; Dell'Aniello S; Agulnik J; Pehr K
J Am Acad Dermatol; 2023 Apr; 88(4):869-870. PubMed ID: 36228936
[No Abstract] [Full Text] [Related]
14. Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta-analysis.
Gorji M; Joseph J; Pavlakis N; Smith SD
Asia Pac J Clin Oncol; 2022 Dec; 18(6):526-539. PubMed ID: 35352492
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab-induced acneiform eruption and the response to isotretinoin.
Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
[No Abstract] [Full Text] [Related]
16. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
Eames T; Landthaler M; Karrer S
Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151
[No Abstract] [Full Text] [Related]
17. Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib.
Anforth R; Liu M; Nguyen B; Uribe P; Kefford R; Clements A; Long GV; Fernandez-Peñas P
Australas J Dermatol; 2014 Nov; 55(4):250-4. PubMed ID: 24313958
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous effects related to the use of tyrosine kinase inhibitors].
Mateus C
Rev Pneumol Clin; 2007 Jan; 63(1 Pt 2):2S16-7. PubMed ID: 17242640
[No Abstract] [Full Text] [Related]
19. [Epidermal growth factor receptor inhibitors side effects].
Guhl G; González-de Arriba A; Daudén E
Actas Dermosifiliogr; 2006 Jun; 97(5):296-310. PubMed ID: 16956561
[TBL] [Abstract][Full Text] [Related]
20. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.
Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A
Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
